Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia

Bone Marrow Transplantation

Volumn 30, Issue 4, 2002, Pages 243-251

  Van Agthoven, M ^a   Groot, M T ^a   Verdonck, L F ^b   Lowenberg B ^c   Schattenberg, A V M B ^d   Oudshoorn, M ^e   Hagenbeek, A ^b   Cornelissen, J J ^c   Uyl de Groot, C A ^a   Willemze, R ^e  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Allogeneic; Bone marrow transplantation; Cost analysis; Stem cell transplantation

Indexed keywords

ANTIBIOTIC AGENT; CYTOSTATIC AGENT; HEMOPOIETIC GROWTH FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ARTICLE; CONTROLLED STUDY; COST UTILITY ANALYSIS; DIAGNOSTIC PROCEDURE; DRUG COST; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HOSPITAL COST; HOSPITAL PERSONNEL; HOSPITALIZATION; HUMAN; LIVING DONOR; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING TEST; SIBLING; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; COST; DONOR; ECONOMICS; FEMALE; HEALTH CARE COST; HISTOCOMPATIBILITY; ISOGRAFT; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE COSTS; HISTOCOMPATIBILITY; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0036675881     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703641     Document Type: Article

References (26)

1. Bone marrow and peripheral blood stem cell transplantation for malignancy
2. Economic analyses of bone marrow and blood stem cell transplantation for leukaemia and lymphoma: What do we know?
3. The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukaemia
4. A comparison of bone marrow transplantation with maintenance chemotherapy for patients with acute nonlymphoblastic leukaemia in first complete remission
5. Cost-effectiveness of bone marrow transplantation in acute non-lymphocytic leukaemia
6. The costs and benefits of bone marrow transplantation
7. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission
8. Economic evaluation of allogeneic bone marrow transplantation: A rudimentary model to generate estimates for the timely formulation of clinical policy
9. Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation
10. Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: Implications for economic analyses of phase III clinical trials
11. Hematopoietic stem cell transplantation activity in Europe 1999
12. Pharmacotherapeutical Compass 1998
13. Allogeneic peripheral blood stem cell transplantation in patients with advanced haematologic malignancies: A retrospective comparison with marrow transplantation
14. Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: Clinical assessment and cost-effectiveness
15. Peripheral blood stem cell transplantation after high-dose therapy in patients with malignant lymphoma: A retrospective comparison with autologous bone marrow transplantation
16. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral -blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma
17. Cost comparative study of autologous peripheral blood progenitor cells (PBPC) and bone marrow (ABM) transplantations for non-Hodgkin's lymphoma patients
18. Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation
19. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed Hodgkin's disease: A prospective randomised trial
20. Recommended criteria for the performance of bone marrow transplantation
21. Standards for specialist units undertaking blood and marrow stem cell transplants - Recommendations from the EBMT
22. Bone marrow transplants using volunteer donors - Recommendations and requirements for a standardized practice throughout the world
23. A special report: Bone marrow transplants using volunteer donors - Recommendations and requirements for a standardized practice throughout the world - 1994 update